Early Promising Results In Malaria Vaccine Trial Announced

A clinical trial has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it. Continue reading ...

Patience may be a virtue -- but for senior citizens planning to downsize from a family home to a Continuing Care Retirement Community, there's a fine line between being patient and waiting too long. Continue reading ...

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, announced that it has received approval of its New Drug Application (NDA) from the U.S. Continue reading ...

Researchers are launching an Alzheimer's screening clinical trial with Neuronetrix's innovative brain scanning system, called COGNISION. Continue reading ...

Alpharma announced availability of FLECTOR Patch 1.3%, the first and only anti-inflammatory pain relief patch in US. Continue reading ...

Most everyone has heard of TMJ, the popular acronym for the temporomandibular joint, and the jaw pain and dysfunction associated with it. Continue reading ...

A new study found that 40 percent of pancreatic cancer patients are diagnosed with diabetes prior to their pancreatic cancer diagnosis. Continue reading ...

Help Evaluate New Diabetes Education Tool, UK

Diabetes UK is working with Healthy Interactions Inc. (Healthyi) to bring diabetes conversation maps to the UK. The three foot by five foot maps roll out flat and feature images and statistics to provide a fun, engaging diabetes education experience. Designed for use in groups of three to ten patients, the maps encourage meaningful discussion about diabetes rather than a one-way lecture. Read more ...

Genaera Corporation (Nasdaq: GENR) announced that the investigational new drug (IND) application submitted to the US Food and Drug Administration (FDA) for trodusquemine (MSI-1436) in type 2 diabetes is now in effect. This application represents the second IND filed by the Company in 2007 for MSI- 1436. A previous IND for the treatment of obesity, under which Genaera is currently conducting phase 1 clinical trials, has been in effect since April 2007. Read more ...

AASM On Sleep Medications And Insomnia Treatment

AASM On Sleep Medications And Insomnia Treatment
People suffering from insomnia need to know that there are effective insomnia treatments and their sleep can improve.

The RNA Drug Revolution: A New Approach to Gene Therapy
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes.

Researchers identify brain's 'eureka' circuitry
Researchers have found the brain region that controls the decision to halt your midnight exploration of the refrigerator and commence enjoyment of that leftover chicken leg.